Literature DB >> 9849723

Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements.

L M Pezawas1, G Fischer, K Diamant, C Schneider, S D Schindler, M Thurnher, W Ploechl, H Eder, S Kasper.   

Abstract

Cerebrospinal fluid (CSF) space enlargement has been demonstrated in substance-related disorders like alcohol and cocaine dependence. Experimental animal studies showed a reduction in shape and size of mesolimbic dopaminergic neurons after chronic morphine administration. Other studies indicated a change of neurofilament and glial fibrillary acid proteins after chronic opiate administration. Furthermore, frequent overdosing and toxicological effects of 'street'-heroin may lead to CSF space enlargement in opioid dependence. In our study the pericortical and ventricular CSF space of 21 male opioid-dependent patients was compared with an age- and sex-matched normal control group. Considering serious problems with ratio and proportion measures, we used a battery of linear (cella media index, Huckman number, frontal horn index), planimetric (cortical atrophy score) and stereological volumetric measures in order to detect differences in cranial computerized tomography scans. We found a significant ventricular and cortical volume loss of the brain in opioid-dependent patients. A higher degree of frontal lobe volume loss seemed to be associated with a shorter period of abstinence before relapse. However, the etiology of volume loss of the brain in opioid-dependent patients is still unclear, but experimental animal studies provide some evidence that long-term, chronic opiate exposure is associated with visible changes of specific structures in the brain.

Entities:  

Mesh:

Year:  1998        PMID: 9849723     DOI: 10.1016/s0925-4927(98)00028-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  21 in total

Review 1.  [Neuroimaging in substance abuse disorders].

Authors:  A de Mendelssohn; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 2.  [Mrt-based morphometry. A current assessment].

Authors:  M Tittgemeyer; D Y von Cramon
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

Review 3.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

4.  Prefrontal and temporal gray matter density decreases in opiate dependence.

Authors:  In Kyoon Lyoo; Mark H Pollack; Marisa M Silveri; Kyung Heup Ahn; Claudia I Diaz; Jaeuk Hwang; Seog Ju Kim; Deborah A Yurgelun-Todd; Marc J Kaufman; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-12-21       Impact factor: 4.530

Review 5.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

6.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

7.  The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 8.  Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Mikhail N Koffarnus; Kirstin M Gatchalian
Journal:  Pharmacol Ther       Date:  2012-02-22       Impact factor: 12.310

9.  Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men.

Authors:  George Fein; Victoria Di Sclafani; Dieter J Meyerhoff
Journal:  Drug Alcohol Depend       Date:  2002-09-01       Impact factor: 4.492

Review 10.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.